to study the effect of vasadi kwath in vatrakta (gout)

assessment of vasadi kwath in vatrakta (gout)- a randomised controlled clinical trial - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060586

Enrollment

Registered

2023-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M200- Deformity of finger(s) Health Condition 2: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: SR URIC ACID >7MG/DL FOR MEN SR URIC ACID >6MG/DL FOR WOMEN CHRONIC CASES OF GOUT

Exclusion criteria

Exclusion criteria: IMMUNOCOMPROMISED PATIENTS OR PATIENTS ON IMMUNOSUPPRESSIVE DRUGS PATIENTS SUFFERING FROM LIFE THREATENING DISEASE PREGNANT WOMEN AND LACTATING MOTHER PATIENTS WITH CHRONIC KIDNEY DISEASE AND END STAGE RENAL DISEASE AND REQUIRING DIALYSIS PATIENTS TAKING DIURETICS ASPIRIN ETHAMBUTOL PYRIZINAMIDE CYCLOSPORINE CYTOTOXIC DRUGS

Design outcomes

Primary

Measure	Time frame
SR URIC ACID LEVEL TO BE DONE BEFORE AND AFTER THE TRIALTimepoint: baseline and after 4 weeks	—

Secondary

Measure	Time frame
SR URIC ACID LEVELSTimepoint: BASELINE & EVERY 1 MONTH	—

Countries

India

Contacts

Public ContactDR GHULE SHUBHAM SUBHASHRAO

DR G.D. POL FOUNDATION Y.M.T AYURVEDIC MEDICAL COLLEGE AND HOSPITAL PG INSTITUTE KHARGHAR

drpandeymahesh@gmail.com09820006082

Outcome results